Elan: Down But Not Out Posted on August 26th
After some discouraging news about two of its drugs, Elan’s stock plummeted 70%. It’s time to buy.
Trackback URLBusiness News Review National business news, international business news and financial news.
This page has been designed specifically for the printed screen. It may look different than the page you were viewing on the web.
Please recycle it when you're done reading.
The URI for this page is { http://business.reviewnews.org }
Please recycle it when you're done reading.
The URI for this page is { http://business.reviewnews.org }